Bausch Health Cos SG&A Expenses 2010-2024 | BHC

Bausch Health Cos sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Bausch Health Cos Annual SG&A Expenses
(Millions of US $)
2023 $2,917
2022 $2,625
2021 $2,624
2020 $2,367
2019 $2,554
2018 $2,473
2017 $2,582
2016 $2,810
2015 $2,700
2014 $2,026
2013 $1,305
2012 $756
2011 $572
2010 $277
2009 $168
Bausch Health Cos Quarterly SG&A Expenses
(Millions of US $)
2024-09-30 $850
2024-06-30 $832
2024-03-31 $794
2023-12-31 $766
2023-09-30 $715
2023-06-30 $711
2023-03-31 $725
2022-12-31 $666
2022-09-30 $661
2022-06-30 $676
2022-03-31 $622
2021-12-31 $680
2021-09-30 $653
2021-06-30 $685
2021-03-31 $606
2020-12-31 $636
2020-09-30 $572
2020-06-30 $526
2020-03-31 $633
2019-12-31 $668
2019-09-30 $648
2019-06-30 $651
2019-03-31 $587
2018-12-31 $626
2018-09-30 $614
2018-06-30 $642
2018-03-31 $591
2017-12-31 $639
2017-09-30 $623
2017-06-30 $659
2017-03-31 $661
2016-12-31 $665
2016-09-30 $661
2016-06-30 $671
2016-03-31 $813
2015-12-31 $743
2015-09-30 $698
2015-06-30 $686
2015-03-31 $574
2014-12-31 $524
2014-09-30 $504
2014-06-30 $516
2014-03-31 $482
2013-12-31 $450
2013-09-30 $356
2013-06-30 $257
2013-03-31 $242
2012-12-31 $205
2012-09-30 $189
2012-06-30 $185
2012-03-31 $177
2011-12-31 $149
2011-09-30 $135
2011-06-30 $150
2011-03-31 $140
2010-12-31 $128
2010-09-30 $60
2010-06-30 $45
2010-03-31 $44
2009-12-31 $30
2009-09-30 $45
2009-06-30 $49
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.358B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.384B 6.36
Dr Reddy's Laboratories (RDY) India $12.329B 23.59
BridgeBio Pharma (BBIO) United States $4.629B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.294B 13.79
Supernus Pharmaceuticals (SUPN) United States $2.089B 28.44
Taysha Gene Therapies (TSHA) United States $0.490B 79.67
Personalis (PSNL) United States $0.278B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00